KR101268215B1 - 알긴산 바디를 포함하는 위장 체류 시스템 - Google Patents

알긴산 바디를 포함하는 위장 체류 시스템 Download PDF

Info

Publication number
KR101268215B1
KR101268215B1 KR1020107000051A KR20107000051A KR101268215B1 KR 101268215 B1 KR101268215 B1 KR 101268215B1 KR 1020107000051 A KR1020107000051 A KR 1020107000051A KR 20107000051 A KR20107000051 A KR 20107000051A KR 101268215 B1 KR101268215 B1 KR 101268215B1
Authority
KR
South Korea
Prior art keywords
retention system
gastrointestinal retention
calcium
swelling body
gastrointestinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020107000051A
Other languages
English (en)
Korean (ko)
Other versions
KR20100028621A (ko
Inventor
보도 아스무쎈
크리스티아네 쉴러
베르너 웨이트쉬에스
Original Assignee
에르테에스 로만 테라피-시스테메 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에르테에스 로만 테라피-시스테메 아게 filed Critical 에르테에스 로만 테라피-시스테메 아게
Publication of KR20100028621A publication Critical patent/KR20100028621A/ko
Application granted granted Critical
Publication of KR101268215B1 publication Critical patent/KR101268215B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020107000051A 2007-06-04 2008-05-27 알긴산 바디를 포함하는 위장 체류 시스템 Expired - Fee Related KR101268215B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007026037.9 2007-06-04
DE102007026037A DE102007026037A1 (de) 2007-06-04 2007-06-04 Gastroretentives System mit Alginat-Körper

Publications (2)

Publication Number Publication Date
KR20100028621A KR20100028621A (ko) 2010-03-12
KR101268215B1 true KR101268215B1 (ko) 2013-05-31

Family

ID=39942026

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020107000051A Expired - Fee Related KR101268215B1 (ko) 2007-06-04 2008-05-27 알긴산 바디를 포함하는 위장 체류 시스템

Country Status (14)

Country Link
US (1) US20100129445A1 (https=)
EP (2) EP2497465A3 (https=)
JP (1) JP5425058B2 (https=)
KR (1) KR101268215B1 (https=)
CN (1) CN102215826A (https=)
AU (1) AU2008258881B2 (https=)
CA (1) CA2689049C (https=)
DE (1) DE102007026037A1 (https=)
IL (1) IL202518A0 (https=)
MX (1) MX2009013086A (https=)
NZ (1) NZ581740A (https=)
RU (1) RU2468790C2 (https=)
WO (1) WO2008148478A2 (https=)
ZA (1) ZA200908355B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11511093B2 (en) 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101118794B1 (ko) * 2009-11-10 2012-06-13 동아제약주식회사 비스포스포네이트를 함유하는 약학 조성물
WO2012083017A2 (en) 2010-12-16 2012-06-21 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
US9532977B2 (en) 2010-12-16 2017-01-03 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
DE102011051653A1 (de) * 2011-07-07 2013-01-10 Lts Lohmann Therapie-Systeme Ag Quellfähige Manteltablette
DK2858604T3 (da) 2012-06-07 2024-05-21 Epitomee Medical Ltd Ekspanderet anordning
EP2887925B1 (en) * 2012-08-27 2017-02-22 Evonik Röhm GmbH Gastric resistant pharmaceutical or nutraceutical composition with resistance against the influence of ethanol
WO2014032676A1 (en) * 2012-09-03 2014-03-06 S-Biotek Holding Aps A solid oral formulation for treatment and/or prevention of overweight and/or for stabilizing blood sugar levels in an individual.
WO2015083171A1 (en) * 2013-12-05 2015-06-11 Tulip Medical Ltd. Retentive devices and systems for in-situ release of pharmaceutical active agents
WO2017083348A1 (en) 2015-11-11 2017-05-18 Celgene Corporation Controlled release oral dosage forms of poorly soluble drugs and uses thereof
CN108721246B (zh) * 2018-05-29 2021-06-25 王喆明 高分子材料构建的多单元超长效口服制剂及其制备方法
KR102278915B1 (ko) 2019-10-24 2021-07-19 중앙대학교 산학협력단 다공성 하이드로겔을 유효성분으로 함유하는 위 체류 및 약물 방출 제어형 경구용 제제
EP4477215A3 (en) 2020-12-08 2025-02-19 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4695463A (en) * 1985-05-24 1987-09-22 Warner-Lambert Company Delivery system for active ingredients and preparation thereof
US4816262A (en) 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
IL87710A (en) 1987-09-18 1992-06-21 Ciba Geigy Ag Covered floating retard form for controlled release in gastric juice
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
US4983401A (en) 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings
US5198227A (en) 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
ATE133331T1 (de) 1991-11-13 1996-02-15 Glaxo Canada Vorrichtung zur kontrollierten wirkstoffreigabe
DE69423643T2 (de) * 1993-10-29 2000-09-07 R.P. Scherer Corp., Troy Schäumende gelatinkapselfüllung
DE4419818C2 (de) 1994-06-07 1998-10-22 Lohmann Therapie Syst Lts Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben
DE4431653C2 (de) 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
DE19537090A1 (de) 1995-10-05 1997-04-10 Lohmann Therapie Syst Lts Osmotische Vorrichtung zur kontinuierlichen Freisetzung von Wirkstoffen in die Flüssigkeiten des Gastrointestinaltraktes
US20020002364A1 (en) * 1995-10-05 2002-01-03 Karsten Cremer Osmotic device for the continuous release of active compounds into the fluids of the gastrointestinal tract
FR2784583B1 (fr) * 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US6497902B1 (en) * 1999-12-01 2002-12-24 The Regents Of The University Of Michigan Ionically crosslinked hydrogels with adjustable gelation time
US6488962B1 (en) 2000-06-20 2002-12-03 Depomed, Inc. Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms
JP2004501190A (ja) 2000-06-23 2004-01-15 テバ　ファーマシューティカル　インダストリーズ　リミティド 治療薬の胃部保留および制御された放出のための急速膨張する組成物とその組成物を含む剤形
DE60212475T2 (de) * 2001-03-14 2007-07-05 Pfizer Products Inc., Groton Pharmazeutische Tablette und ein Verfahren zu ihrer Herstellung
EP1245227A1 (en) 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
MXPA03012041A (es) 2001-07-04 2004-03-26 Sun Pharmaceutical Ind Ltd Sistema de administracion controlada de farmacos de retencion gastrica.
US20040219186A1 (en) 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
IN191024B (https=) * 2001-09-25 2003-09-13 J B Chemicals And Pharmaceutic
WO2004002445A2 (en) 2002-06-26 2004-01-08 Cadila Healthcare Limited Novel floating dosage form
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11511093B2 (en) 2019-10-11 2022-11-29 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor
US12465735B2 (en) 2019-10-11 2025-11-11 Wonkwang University Center for Industry Academy Cooperation Gastroretentive drug delivery device having expandable structure and manufacturing method therefor

Also Published As

Publication number Publication date
KR20100028621A (ko) 2010-03-12
WO2008148478A3 (de) 2009-04-09
CA2689049C (en) 2014-07-08
CA2689049A1 (en) 2008-12-11
AU2008258881B2 (en) 2013-12-19
EP2155172A2 (de) 2010-02-24
JP2010529056A (ja) 2010-08-26
EP2497465A3 (de) 2012-11-21
RU2468790C2 (ru) 2012-12-10
ZA200908355B (en) 2010-07-28
MX2009013086A (es) 2010-01-18
WO2008148478A8 (de) 2009-02-05
EP2497465A2 (de) 2012-09-12
WO2008148478A2 (de) 2008-12-11
NZ581740A (en) 2011-05-27
US20100129445A1 (en) 2010-05-27
DE102007026037A1 (de) 2008-12-11
AU2008258881A1 (en) 2008-12-11
IL202518A0 (en) 2010-06-30
RU2009147730A (ru) 2011-06-27
JP5425058B2 (ja) 2014-02-26
CN102215826A (zh) 2011-10-12

Similar Documents

Publication Publication Date Title
KR101268215B1 (ko) 알긴산 바디를 포함하는 위장 체류 시스템
US12042559B2 (en) Gastroretentive dosage forms for sustained drug delivery
Krögel et al. Floating or pulsatile drug delivery systems based on coated effervescent cores
Shaha et al. An overview of a gastro-retentive floating drug delivery system
FI113941B (fi) Menetelmä pH-herkällä laukaisimella varustettujen, osmoottisten, hajoavien välineiden valmistamiseksi aineen vapauttamiseksi
ES2163504T5 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2561478T3 (es) Proceso de fabricación de formas de dosificación de retención gástrica
EP3970701B1 (en) Self-regulating osmotic gastroretentive drug delivery systems
NO178095B (no) Fremgangsmåte for fremstilling av et omhyllet farmasöytisk retarderingspreparat
MXPA05005812A (es) Liberacion controlada de una sustancia activa a un entorno rico en grasa.
DK1916995T3 (en) PH-CONTROLLED, PULSED delivery, METHODS OF MAKING AND USE THEREOF
JP2024054132A (ja) リオチロニンを含む持続放出組成物
Patil et al. Floating microspheres: A promising approach for gastric retention
Katakam et al. Floating drug delivery systems: a review
JP5563735B2 (ja) Ｐｐｉ多回剤形
Kharat et al. RECENT INNOVATIONS IN GASTRO-RETENTIVE DRUG DELIVERY SYSTEM AND ITS PROSPECT IN THE FUTURE
KHARAT et al. Indian Journal of Novel Drug Delivery
Gavali et al. Suitable polymers in floating gastroretentive drug delivery
Dey et al. Floating drug delivery system
JPWO2007069358A1 (ja) 新規胃内滞留製剤
NZ565272A (en) pH-controlled pulsatile delivery system, methods for preparation and use thereof

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

AMND Amendment
J201 Request for trial against refusal decision
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PJ0201 Trial against decision of rejection

St.27 status event code: A-3-3-V10-V11-apl-PJ0201

PB0901 Examination by re-examination before a trial

St.27 status event code: A-6-3-E10-E12-rex-PB0901

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

St.27 status event code: A-3-4-F10-F13-rex-PB0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20160522

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20160522